跳转至内容
Merck
CN
  • [Results of open multicenter study of the safety of doxazosin in combination with indigal in men with stages I-II prostatic adenoma].

[Results of open multicenter study of the safety of doxazosin in combination with indigal in men with stages I-II prostatic adenoma].

Urologiia (Moscow, Russia : 1999) (2013-06-26)
V N Pavlov, B K Komiakov, M É Grigor'ev, A V Sivkov, B I Bliumberg, A A Kazikhinoruv, A A Izmaĭlov, A V Boiarko, R A Abzalilov
摘要

The article presents a method of conservative treatment of men with I-II stage prostatic adenoma using a combination of doxazosin and indigal, which has antioxidant, antiproliferative and anti-inflammatory properties, that allowed improving urodynamic parameters and reducing the progression prostate adenoma, minimizing the adverse effects of treatment.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
(-)-表没食子儿茶素没食子酸酯, ≥95%
Sigma-Aldrich
(−)-表儿茶素, ≥90% (HPLC)
Sigma-Aldrich
(-)-表没食子儿茶素没食子酸酯, ≥80% (HPLC), from green tea
Sigma-Aldrich
(−)-表儿茶素, ≥98% (HPLC), from green tea
Sigma-Aldrich
吲哚-3-甲醇
Supelco
(+)-儿茶素, analytical standard
Supelco
(-)-表没食子儿茶素没食子酸酯, analytical standard
(−)-表儿茶素, primary reference standard
Supelco
(−)-表儿茶素, analytical standard
(-)-表没食子儿茶素没食子酸酯, primary reference standard
Sigma-Aldrich
多沙唑嗪 甲磺酸酯, ≥97% (HPLC), powder